Image from Google Jackets

Effect of glargine addition to NPH or premixed insulin on glycaemic control in patients with type 2 diabetes / Eleanor A. Paculan-Luna ; Cynthia Chua-Ho ; Maellen Grace S. Alferos.

By: Contributor(s): Language: English Publication details: Fairview, Quezon City Department of Medicine, FEU-NRMF, 2004Description: illustrations; (in folder)Content type:
  • text
Media type:
  • unmediated
Carrier type:
  • volume
LOC classification:
  • MED20040002
Summary: ABSTRACT: Insulin Glargine is a novel recombinant analogue of human insulin with a shift in the isoelectric point producing a retarded absorption rate and an increased duration of action that closely mimies normal basal insulin secretion. Insulin treatment can improve and maintain glycaemic control, preventing long term complications in type 2 diabetes.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Status Date due Barcode
Research Far Eastern University - Nicanor Reyes Medical Foundation Research MED20040002 (Browse shelf(Opens below)) Available R000111

Includes appendices and bibliographical references.

ABSTRACT: Insulin Glargine is a novel recombinant analogue of human insulin with a shift in the isoelectric point producing a retarded absorption rate and an increased duration of action that closely mimies normal basal insulin secretion. Insulin treatment can improve and maintain glycaemic control, preventing long term complications in type 2 diabetes.

Research - Department of Medicine

There are no comments on this title.

to post a comment.